The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The regulation of protein phosphorylation
Abstract
Phosphorylation plays essential roles in nearly every aspect of cell life. Protein kinases regulate signalling pathways and cellular processes that mediate metabolism, transcription, cell-cycle progression, differentiation, cytoskeleton arrangement and cell movement, apoptosis, intercellular communication, and neuronal and immunological functions. Protein kinases share a conserved catalytic domain, which catalyses the transfer of the γ-phosphate of ATP to a serine, threonine or tyrosine residue in protein substrates. The kinase can exist in an active or inactive state regulated by a variety of mechanisms in different kinases that include control by phosphorylation, regulation by additional domains that may target other molecules, binding and regulation by additional subunits, and control by protein–protein association. This Novartis Medal Lecture was delivered at a meeting on protein evolution celebrating the 200th anniversary of Charles Darwin's birth. I begin with a summary of current observations from protein sequences of kinase phylogeny. I then review the structural consequences of protein phosphorylation using our work on glycogen phosphorylase to illustrate one of the more dramatic consequences of phosphorylation. Regulation of protein phosphorylation is frequently disrupted in the diseased state, and protein kinases have become high-profile targets for drug development. Finally, I consider recent advances on protein kinases as drug targets and describe some of our recent work with CDK9 (cyclin-dependent kinase 9)–cyclin T, a regulator of transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.09.026 · Cited by 3,499
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
Stamos, J., Sliwkowski, M. X., & Eigenbrot, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207135200 · Cited by 1,574
An Adenosine 3′,5′-Monophosphate-dependant Protein Kinase from Rabbit Skeletal Muscle
Walsh, D. A., Perkins, J. P., & Krebs, E. G. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34204-8 · Cited by 1,445
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
Jeffrey, P. D., Russo, A. A., Polyak, K., Gibbs, E., Hurwitz, J., Massagué, J., & Pavletich, N. P. (1995) · Nature · doi:10.1038/376313a0 · Cited by 1,436
Yun, C.-H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., & Eck, M. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.017 · Cited by 1,192
The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans
King, N., Westbrook, M. J., Young, S. L., Kuo, A., Abedin, M., Chapman, J., Fairclough, S., Hellsten, U., Isogai, Y., Letunic, I., et al. (2008) · Nature · doi:10.1038/nature06617 · Cited by 1,139
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D., Hassell, A., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,122
Rational design of inhibitors that bind to inactive kinase conformations
Liu, Y., & Gray, N. S. (2006) · Nature Chemical Biology · doi:10.1038/nchembio799 · Cited by 1,094
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
Crystal structure of cyclin-dependent kinase 2
De Bondt, H. L., Rosenblatt, J., Jancarik, J., Jones, H. D., Morgan, D. O., & Kim, S.-H. (1993) · Nature · doi:10.1038/363595a0 · Cited by 976
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb770 · Cited by 833
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
Ortega, S., Prieto, I., Odajima, J., Martín, A., Dubus, P., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 796
Three-dimensional structure of the Stat3β homodimer bound to DNA
Becker, S., Groner, B., & Müller, C. W. (1998) · Nature · doi:10.1038/28101 · Cited by 788
Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H., & Goldsmith, E. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80351-7 · Cited by 729
Radhakrishnan, I., Pérez-Alvarado, G. C., Parker, D., Dyson, H. J., Montminy, M. R., & Wright, P. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80463-8 · Cited by 728
Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA
Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J. E., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81443-9 · Cited by 720
THE STRUCTURE AND MECHANISM OF PROTEIN PHOSPHATASES: Insights into Catalysis and Regulation
Barford, D., Das, A. K., & Egloff, M.-P. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.133 · Cited by 706
Tokarski, J. S., Newitt, J. A., Chang, C. Y. J., Cheng, J. D., Wittekind, M., Kiefer, S. E., Kish, K., Lee, F. Y. F., Borzillerri, R., Lombardo, L. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4187 · Cited by 700
Protein phosphorylation in signaling – 50 years and counting
Pawson, T., & Scott, J. D. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.04.013 · Cited by 694
Berthet, C., Aleem, E., Coppola, V., Tessarollo, L., & Kaldis, P. (2003) · Current Biology · doi:10.1016/j.cub.2003.09.024 · Cited by 663
Structural Basis for Control by Phosphorylation
Johnson, L. N., & Lewis, R. J. (2001) · Chemical Reviews · doi:10.1021/cr000225s · Cited by 636
Self-citationOhren, J. F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell, P., Spessard, C., Banotai, C., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb859 · Cited by 626
Structural basis of cyclin-dependent kinase activation by phosphorylation
Russo, A. A., Jeffrey, P. D., & Pavletich, N. P. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-696 · Cited by 598
Brown, N. R., Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (1999) · Nature Cell Biology · doi:10.1038/15674 · Cited by 546
Self-citationCONVERSION OF PHOSPHORYLASE b TO PHOSPHORYLASE a IN MUSCLE EXTRACTS
Fischer, E. H., & Krebs, E. G. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52289-x · Cited by 543
An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates
Eckhart, W., Hutchinson, M. A., & Hunter, T. (1979) · Cell · doi:10.1016/0092-8674(79)90205-8 · Cited by 525
Liao, J. J.-L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0608107 · Cited by 507
De Azevedo, W. F., Mueller-Dieckmann, H. J., Schulze-Gahmen, U., Worland, P. J., Sausville, E., & Kim, S. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2735 · Cited by 496
Proliferation of cancer cells despite CDK2 inhibition
Tetsu, O., & McCormick, F. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 466
Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication
Chao, S.-H., Fujinaga, K., Marion, J. E., Taube, R., Sausville, E. A., Senderowicz, A. M., Peterlin, B. M., & Price, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000446200 · Cited by 455
Byrd, J. C., Lin, T. S., Dalton, J. T., Wu, D., Phelps, M. A., Fischer, B., Moran, M., Blum, K. A., Rovin, B., Brooker-McEldowney, M., et al. (2007) · Blood · doi:10.1182/blood-2006-05-020735 · Cited by 390
Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia
Raval, A., Tanner, S. M., Byrd, J. C., Angerman, E. B., Perko, J. D., Chen, S.-S., Hackanson, B., Grever, M. R., Lucas, D. M., Matkovic, J. J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.043 · Cited by 371
Baumli, S., Lolli, G., Lowe, E. D., Troiani, S., Rusconi, L., Bullock, A. N., Debreczeni, J. É., Knapp, S., & Johnson, L. N. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.121 · Cited by 353
Self-citationCyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329
Mechanisms of drug inhibition of signalling molecules
Sebolt-Leopold, J. S., & English, J. M. (2006) · Nature · doi:10.1038/nature04874 · Cited by 304
Structure and function of Polo-like kinases
Lowery, D. M., Lim, D., & Yaffe, M. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208280 · Cited by 293
Structure and Regulation of the CDK5-p25nck5a Complex
Tarricone, C., Dhavan, R., Peng, J., Areces, L. B., Tsai, L.-H., & Musacchio, A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00343-4 · Cited by 280
The Effects of Phosphorylation on the Structure and Function of Proteins
Johnson, L. N., & Barford, D. (1993) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.bb.22.060193.001215 · Cited by 264
Self-citationRubin, S. M., Gall, A.-L., Zheng, N., & Pavletich, N. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.044 · Cited by 257
Molecular Basis for the Recognition of Phosphorylated and Phosphoacetylated Histone H3 by 14-3-3
Macdonald, N., Welburn, J. P. I., Noble, M. E. M., Nguyen, A., Yaffe, M. B., Clynes, D., Moggs, J. G., Orphanides, G., Thomson, S., Edmunds, J. W., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.032 · Cited by 257
Protein kinase inhibitors: contributions from structure to clinical compounds
Johnson, L. N. (2009) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583508004745 · Cited by 256
Self-citationEvolution of protein phosphatases in plants and animals
Moorhead, G. B. G., De Wever, V., Templeton, G., & Kerk, D. (2009) · Biochemical Journal · doi:10.1042/bj20081986 · Cited by 254
CDK inhibitors in cancer therapy: what is next?
Malumbres, M., Pevarello, P., Barbacid, M., & Bischoff, J. R. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.012 · Cited by 240
Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP
Barford, D., Hu, S.-H., & Johnson, L. N. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90887-c · Cited by 240
Self-citationSeeliger, M. A., Nagar, B., Frank, F., Cao, X., Henderson, M. N., & Kuriyan, J. (2007) · Structure · doi:10.1016/j.str.2007.01.015 · Cited by 221
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor
Davies, T. G., Bentley, J., Arris, C. E., Boyle, F. T., Curtin, N. J., Endicott, J. A., Gibson, A. E., Golding, B. T., Griffin, R. J., Hardcastle, I. R., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb842 · Cited by 219
Self-citationManning, G., Young, S. L., Miller, W. T., & Zhai, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801314105 · Cited by 209
Filippakopoulos, P., Kofler, M., Hantschel, O., Gish, G. D., Grebien, F., Salah, E., Neudecker, P., Kay, L. E., Turk, B. E., Superti-Furga, G., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.047 · Cited by 201
Lowe, E. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.22.6646 · Cited by 199
The crystal structure of cyclin A
Brown, N., Noble, M., Endicott, J., Garman, E., Wakatsuki, S., Mitchell, E., Rasmussen, B., Hunt, T., & Johnson, L. (1995) · Structure · doi:10.1016/s0969-2126(01)00259-3 · Cited by 191
Self-citationThe structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2‐independent roles
Honda, R., Lowe, E. D., Dubinina, E., Skamnaki, V., Cook, A., Brown, N. R., & Johnson, L. N. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600554 · Cited by 172
Self-citationSebolt-Leopold, J. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0333 · Cited by 167
Evolution of the phospho-tyrosine signaling machinery in premetazoan lineages
Pincus, D., Letunic, I., Bork, P., & Lim, W. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803161105 · Cited by 165
The Rice Kinase Database. A Phylogenomic Database for the Rice Kinome
Dardick, C., Chen, J., Richter, T., Ouyang, S., & Ronald, P. (2007) · Plant Physiology · doi:10.1104/pp.106.087270 · Cited by 163
Owen, D., Noble, M., Garman, E. F., Papageorigiou, A., & Johnson, L. (1995) · Structure · doi:10.1016/s0969-2126(01)00180-0 · Cited by 148
Self-citationStrengths of Hydrogen Bonds Involving Phosphorylated Amino Acid Side Chains
Mandell, D. J., Chorny, I., Groban, E. S., Wong, S., Levine, E., Rapp, C. S., & Jacobson, M. P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja063019w · Cited by 135
The functional repertoires of metazoan genomes
Ponting, C. P. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2413 · Cited by 123
The structure of CDK4/cyclin D3 has implications for models of CDK activation
Takaki, T., Echalier, A., Brown, N. R., Hunt, T., Endicott, J., & Noble, M. E. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809674106 · Cited by 120
Kinomer v. 1.0: a database of systematically classified eukaryotic protein kinases
Martin, D. M. A., Miranda‐Saavedra, D., & Barton, G. J. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn834 · Cited by 109
Watson, K. A., McCleverty, C., Geremia, S., Cottaz, S., Driguez, H., & Johnson, L. N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4619 · Cited by 105
Self-citationCyclin B and Cyclin A Confer Different Substrate Recognition Properties on CDK2
Brown, N. R., Lowe, E. D., Petri, E. T., Skamnaki, V., Antrobus, R., & Johnson, L. N. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4278 · Cited by 102
Self-citationHow Tyrosine 15 Phosphorylation Inhibits the Activity of Cyclin-dependent Kinase 2-Cyclin A
Welburn, J. P. I., Tucker, J. A., Johnson, T., Lindert, L. M., Morgan, M., Willis, A. C., Noble, M. E. M., & Endicott, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609151200 · Cited by 101
A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol
Shah, M. A., Kortmansky, J. S., Motwani, M., Drobnjak, M., Gönen, M., Yi, S., Weyerbacher, A. R., Cordon‐Cardo, C., Lefkowitz, R. A., Brenner, B., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2651 · Cited by 101
Structure-based design of cyclin-dependent kinase inhibitors
Davies, T. G., Pratt, D. J., Endicott, J., Johnson, L. N., & Noble, M. E. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00182-1 · Cited by 97
Self-citationFornier, M. N., Rathkopf, D. E., Shah, M. H., Patil, S., O'Reilly, E. M., Tse, A. N., Hudis, C., Lefkowitz, R. A., Kelsen, D. P., & Schwartz, G. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1218 · Cited by 92
Watson, K. A., Schinzel, R., Palm, D., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.1 · Cited by 77
Fakler, B., Antz, C., Bauer, T., Kalbacher, H., Frank, R. W., Covarrubias, M., Kalbitzer, H. R., Ruppersberg, J. P., & Baukrowitz, T. (1999) · Nature Structural Biology · doi:10.1038/5833 · Cited by 75
Hurley, J. H., Dean, A. M., Thorsness, P. E., Koshland, D. E., & Stroud, R. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39632-2 · Cited by 75
Ferrarese, A., Marin, O., Bustos, V., Venerando, A., Antonelli, M., Allende, J. E., & Pinna, L. A. (2007) · Biochemistry · doi:10.1021/bi701674z · Cited by 41
Vénien‐Bryan, C., Jonić, S., Skamnaki, V. T., Brown, N., Bischler, N., Oikonomakos, N. G., Boisset, N., & Johnson, L. N. (2009) · Structure · doi:10.1016/j.str.2008.10.013 · Cited by 35
Self-citationDistinct phosphorylation signals converge at the catalytic center in glycogen phosphorylases
Lin, K. F., Hwang, P. K., & Fletterick, R. J. (1997) · Structure · doi:10.1016/s0969-2126(97)00300-6 · Cited by 28
Cited by
Serrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 814
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
Current anti-diabetic agents and their molecular targets: A review
Kerru, N., Singh-Pillay, A., Awolade, P., & Singh, P. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.061 · Cited by 369
Prabakaran, S., Lippens, G., Steen, H., & Gunawardena, J. (2012) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1185 · Cited by 335
The post-translational modification, SUMOylation, and cancer (Review)
Han, Z.-J., Feng, Y.-H., Gu, B.-H., Li, Y.-M., & Chen, H. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4280 · Cited by 334
Metadata
- Authors
- Johnson, L. N.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2009-07-22
- Volume
- 37
- Issue
- 4
- Pages
- 627-641
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2064371632
- Cited by
- 291
- References
- 77
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.